title: Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
authors.affiliation: Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Falanga
authors.affiliation: Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Marina
authors.initials: M
authors.lastname: Marchetti
authors.affiliation: Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
authors.forename: Daniela
authors.initials: D
authors.lastname: Massi
authors.affiliation: Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Barbara
authors.initials: B
authors.lastname: Merelli
authors.affiliation: Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Verzeroli
authors.affiliation: Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Russo
authors.affiliation: Department of Oncology, Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy.
authors.forename: Eliana
authors.initials: E
authors.lastname: Rulli
authors.affiliation: Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Tondini
authors.affiliation: Department of Oncology, Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Legramandi
authors.affiliation: Unit of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
authors.forename: Romina
authors.initials: R
authors.lastname: Nassini
authors.affiliation: Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
authors.forename: Cristian
authors.initials: C
authors.lastname: Scatena
authors.affiliation: Unit of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: De Logu
authors.affiliation: Division of Pathological Anatomy, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Cattaneo
authors.affiliation: Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy. Electronic address: mariomandala@tin.it.
authors.forename: Mario
authors.initials: M
authors.lastname: Mandalà
mesh_terms: D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D018572:Disease-Free Survival; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000097:blood / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary*; D009154:Mutation; D009367:Neoplasm Staging; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D012878:Skin Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D015996:Survival Rate; D019851:Thrombophilia / Q000097:blood*
chemical_list: D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D047428:Protein Kinase Inhibitors; C036309:fibrin fragment D; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf